Bionik Laboratories Corp. (BNKL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.82 Million USD | -1.1% |
| 2022 | -4.77 Million USD | 22.46% |
| 2021 | -6.15 Million USD | 45.27% |
| 2020 | -11.24 Million USD | -54.26% |
| 2019 | -7.29 Million USD | 27.38% |
| 2018 | -10.03 Million USD | -26.2% |
| 2017 | -7.95 Million USD | -19.92% |
| 2016 | -6.63 Million USD | -22363.32% |
| 2015 | -29.52 Thousand USD | -125.25% |
| 2014 | -13.1 Thousand USD | -45.56% |
| 2013 | -9006.00 USD | -101.07% |
| 2012 | -4479.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | - USD | 100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q2 | -1.11 Million USD | 19.08% |
| 2023 FY | -4.82 Million USD | -1.1% |
| 2023 Q1 | -1.37 Million USD | 2.0% |
| 2023 Q4 | -1.29 Million USD | -24.32% |
| 2023 Q3 | -1.04 Million USD | 6.1% |
| 2022 Q4 | -1.4 Million USD | 8.28% |
| 2022 Q3 | -1.52 Million USD | -46.68% |
| 2022 Q2 | -1.04 Million USD | -29.89% |
| 2022 FY | -4.77 Million USD | 22.46% |
| 2022 Q1 | -801.88 Thousand USD | 17.05% |
| 2021 Q4 | -966.75 Thousand USD | 89.1% |
| 2021 Q1 | -1.9 Million USD | 28.25% |
| 2021 Q2 | -1.47 Million USD | 22.59% |
| 2021 FY | -6.15 Million USD | 45.27% |
| 2021 Q3 | -8.86 Million USD | -499.94% |
| 2020 Q2 | -3.37 Million USD | -54.72% |
| 2020 Q3 | -3.02 Million USD | 10.48% |
| 2020 Q4 | -2.66 Million USD | 11.97% |
| 2020 FY | -11.24 Million USD | -54.26% |
| 2020 Q1 | -2.18 Million USD | 11.5% |
| 2019 Q3 | -2.11 Million USD | -3.65% |
| 2019 FY | -7.29 Million USD | 27.38% |
| 2019 Q1 | -667.58 Thousand USD | 74.83% |
| 2019 Q2 | -2.04 Million USD | -205.7% |
| 2019 Q4 | -2.46 Million USD | -16.61% |
| 2018 Q2 | -3.52 Million USD | -70.39% |
| 2018 Q4 | -2.65 Million USD | -35.38% |
| 2018 Q1 | -2.06 Million USD | 32.44% |
| 2018 FY | -10.03 Million USD | -26.2% |
| 2018 Q3 | -1.95 Million USD | 44.44% |
| 2017 FY | -7.95 Million USD | -19.92% |
| 2017 Q2 | -3.93 Million USD | -103.93% |
| 2017 Q3 | -1.56 Million USD | 60.11% |
| 2017 Q4 | -3.06 Million USD | -95.34% |
| 2017 Q1 | -1.92 Million USD | 1.39% |
| 2016 Q1 | -2.43 Million USD | -95.23% |
| 2016 Q4 | -1.95 Million USD | -88.93% |
| 2016 Q3 | -1.03 Million USD | 12.52% |
| 2016 Q2 | -1.18 Million USD | 51.41% |
| 2016 FY | -6.63 Million USD | -22363.32% |
| 2015 Q1 | -3567.00 USD | -288.99% |
| 2015 FY | -29.52 Thousand USD | -125.25% |
| 2015 Q4 | -1.24 Million USD | -5168.39% |
| 2015 Q3 | -23.66 Thousand USD | -1617.42% |
| 2015 Q2 | -1378.00 USD | 61.37% |
| 2014 Q1 | -5820.00 USD | -101.94% |
| 2014 FY | -13.1 Thousand USD | -45.56% |
| 2014 Q4 | -917.00 USD | 65.16% |
| 2014 Q3 | -2632.00 USD | -48.28% |
| 2014 Q2 | -1775.00 USD | 69.5% |
| 2013 Q2 | 1141.00 USD | -69.98% |
| 2013 Q3 | -12.11 Thousand USD | -1162.14% |
| 2013 Q4 | -2882.00 USD | 76.22% |
| 2013 FY | -9006.00 USD | -101.07% |
| 2013 Q1 | 3801.00 USD | 307.82% |
| 2012 Q1 | - USD | 100.0% |
| 2012 FY | -4479.00 USD | 0.0% |
| 2012 Q4 | -1829.00 USD | 60.74% |
| 2012 Q3 | -4659.00 USD | -437.61% |
| 2012 Q2 | 1380.00 USD | 0.0% |
| 2011 Q4 | -1200.00 USD | 0.0% |
| 2011 Q2 | -4629.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -25.84 Million USD | 81.328% |
| Arem Pacific Corporation | -23.6 Thousand USD | -20344.214% |
| Assisted 4 Living, Inc. | -121.58 Thousand USD | -3868.58% |
| BioCorRx Inc. | -3.78 Million USD | -27.384% |
| Banyan Corp. | -1.59 Million USD | -202.722% |
| Clearday, Inc. | -11.85 Million USD | 59.29% |
| Dental Patient Care America, Inc. | -31.55 Thousand USD | -15189.917% |
| Quantum Medical Transport, Inc. | 222.84 USD | 2165348.16% |
| Empower Clinics Inc. | -4.95 Million USD | 2.609% |
| First Choice Healthcare Solutions, Inc. | -2.41 Million USD | -100.173% |
| Selectis Health, Inc. | -8.96 Million USD | 46.152% |
| Ethema Health Corporation | -541.92 Thousand USD | -790.36% |
| HealthLynked Corp. | -3.83 Million USD | -25.923% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | -81.776% |
| JRSIS Health Care Corporation | -188.59 Thousand USD | -2458.372% |
| Comjoyful International Company | - USD | Infinity% |
| Medical Facilities Corporation | 67.1 Million USD | 107.19% |
| MedSmart Group Inc. | -84.51 Thousand USD | -5609.43% |
| North America Frac Sand, Inc. | -702.5 Thousand USD | -586.838% |
| Nova Leap Health Corp. | 460.15 Thousand USD | 1148.575% |
| Nexteligent Holdings, Inc. | -201.72 Thousand USD | -2291.878% |
| PAO Group, Inc. | -45.42 Thousand USD | -10523.159% |
| Primemd Inc. | 4.15 Million USD | 216.021% |
| Raffles Medical Group Ltd | 87.71 Million USD | 105.501% |
| Ryman Healthcare Limited | -26.98 Million USD | 82.121% |
| Stem Cell Authority, Ltd. | -4230.00 USD | -113967.116% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.25 Million USD | -114.371% |
| Mycotopia Therapies, Inc. | -616.72 Thousand USD | -682.366% |
| U.S. NeuroSurgical Holdings, Inc. | -765 Thousand USD | -530.724% |
| Veltex Corporation | -1.08 Million USD | -345.721% |
| World Financial Holding Group | -28.43 Thousand USD | -16871.646% |
| Xcelerate Inc. | -2.61 Million USD | -84.679% |